Peking Union Medical College Hospital
Beijing, 100730, China
NCT Number: NCT03055676
The aim of this randomized prospective multicenter study is to demonstrate the hypothesis that early removal of drain could reduce the incidence of major complications (grade 2-4) after pancreaticoduodenectomy (PD) , when compared with later removal of drain.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Beijing, 100730, China
The objective of this randomized prospective multicenter study is to investigate the association between the time of removal of drain after pancreaticoduodenectomy (PD) and incidence of major complications (grade 2-4 complications). The investigators unite six pancreatic surgery center in Beijing. Patients who underwent pancreaticoduodenectomy (PD) or pylorus-preserving pancreaticoduodenectomy (PPPD) with low to moderate risk of post-operative pancreatic fistula (POPF) are recruited into the study. After obtaining informed consent, eligible patients are randomly allocated to early or late drain removal group on POD 3. In the group A, drain(s) are removed on POD 3, whereas in group B drain is removed on POD 5 or beyond. The primary outcomes are the incidence of sum of grade 2-4 complications, the secondary outcomes include grade B/C POPF, intra-abdominal infeciton, delayed gastric emptying, post-operative bleeding, in-hospital stay, total medical cost and comprehensive complication index (CCI).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Removing drain(s) on postoperative day 3
Removing drain(s) on postoperative day 5 or later
Time frame: Up to postoperative 90 days
The severity of complication was measured by Clavein Dindo classifications and grade 2- 4 complications always affect the recovery of the patients significantly.However, the death case (grade 5 complication) is rare now for PD in high volume centers. According to our single center study, early drain removal could reduce the rate of grade 2-4 complications by 12% for the patients undergoing major pancreatectomy.
Time frame: Up to postoperative 90 days
The International Study Group of Pancreatic Surgery (ISGPS) definition: Blood loss through abdominal drains or nasogastric tube;hematemesis or melena; clinical deterioration of the patient; unexplained hypotension or tachycardia; or laboratory findings such as a decreasing hemoglobin concentration.
Time frame: Up to postoperative 90 days
The International Study Group of Pancreatic Surgery (ISGPS) definition: Inability to return to a standard diet by the end of the first postoperative week with prolonged nasogastric intubation.
Time frame: Up to postoperative 90 days
The International Study Group of Pancreatic Surgery (ISGPS) definition
Time frame: Up to postoperative 90 days
Participants will be followed for the duration of hospital stay, an expected average of 2 weeks.
Time frame: Up to postoperative 90 days
integrates all complications of the Clavien-Dindo classification (CDC) and offers a metric approach to measure morbidity.
Time frame: Up to postoperative 90 days
interventional treatment for any complication.
Time frame: Up to postoperative 90 days
Total medical expenses during hospitalization.
Time frame: Up to postoperative 90 days
Clavein Dindo Classification is adopted.
Peking Union Medical College Hospital
Other
A Randomized Prospective Multicenter Trial of Early Versus Late Drain Removal After Pancreaticoduodenectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01950845
Colorectal Surgery, Hepatectomy
Pierre-Bénite, France
View Trial DetailsNCT04171440
Pancreaticoduodenectomy
Baltimore, Maryland, United States
View Trial DetailsNCT07159672
Digestive System Diseases, Digestive System Neoplasms
Ribeirão Preto, São Paulo, Brazil
View Trial DetailsNCT07038161
Distal Pancreatectomy, Pancreaticoduodenectomy
Kathmandu, Bagmati, Nepal
View Trial Details